MDGL at Evercore yesterday | Biotech Message Board Posts


Biotech   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  48854 of 50472  at  12/2/2023 9:55:44 PM  by

gizmondo123


 In response to msg 48847 by  lbl4321
view thread

Re: MDGL at Evercore yesterday

“ICER analyses suggest resmetirom would achieve common thresholds for cost-effectiveness if priced between $39,600 – $50,100 per year assuming that short-term effects on liver fibrosis translate into longer-term reductions in cirrhosis” I’m not familiar with how or if ICER price ranges affect insurance coverage, anyone?


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
48856 Re: MDGL at Evercore yesterday sling5 0 12/3/2023 12:42:33 PM




Financial Market Data provided by
.
Loading...